Clinical trial

β-AARC: Cohort Study for the Identification of Blood-based Biomarkers in a Population With Subjective Cognitive Decline

NCT04935372

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Observational Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

β-AARC: Cohort Study for the Identification of Blood-based Biomarkers in a Population With Subjective Cognitive Decline

Design: OBSERVATIONAL · Status: ACTIVE NOT RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2021-05-25

PhaseN/A

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Preclinical Alzheimerunresolved

Mild Cognitive Impairmentunresolved

Interventions

ObservationalOTHER

Sponsors & collaborators

Barcelonabeta Brain Research Center, Pasqual Maragall Foundationlead sponsor

Mapped research locations

BarcelonaBarcelona, Spain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04935372 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.